Throughout the year, Capsugel hosts and participates in numerous webinars and virtual conferences. Each of these activities gives us an opportunity to showcase our latest products and services, build relationships with customers and partners, and share and gain invaluable insights.
Webinar |
---|
API in Capsule: A Smart Approach for Rapid Drug DevelopmentSeptember 29, 2016 11 AM ET (5 PM CET) Market Segment: Pharmaceutical Micro-dosing in Today’s Pharmaceutical Industry Micro-dosing is the procedure of dispensing precise amounts of drug substance into capsules (powder-in-capsule or PIC). Capsugel’s proprietary Xcelodose® Precision Powder Micro-dosing System facilitates the PIC approach by providing accurate, consistent and automated fill across compound types inclusive of very low dose applications. Xcelodose Systems have become the industry standard for micro-dosing with rapid PIC manufacture and fill accuracy to 100 micrograms. Micro-dosing best practices have been developed by Xcelience, based on the experience of more than 600 batches and 200 compounds, utilizing Xcelodose Systems to reduce product development time by 13-17 weeks. Key Learning Objectives:
Presented by:
API in Capsule: A Smart Approach for Rapid Drug DevelopmentSeptember 29, 2016 11 AM ET (5 PM CET) Market Segment: Pharmaceutical Click here for access |
Enabling Formulation of Water-Soluble and Water-Insoluble Molecules using a Lipophilic Salt ApproachSeptember 27, 2016 11 AM ET (5 PM CET) Market Segment: Pharmaceutical Pharmaceutical salts have traditionally been used to address formulation issues, including solubility. Preliminary in vitro and in vivo studies indicate that a lipophilic salt selection approach enables lipid formulations by supporting substantially higher loadings—more than 10-fold in some cases—and increased solubilization in the GI tract than otherwise possible using free API. The use of lipophilic salt forms can give more APIs access to the well-established benefits of lipid formulations by overcoming certain product design constraints, such as the number and/or size of dosage unit. This webcast will describe an approach to prepare lipophilic salt forms for a range of APIs and formulate these in concentrated lipid formulations ready for oral delivery. Key Learning Objectives:
Presented by:
Enabling Formulation of Water-Soluble and Water-Insoluble Molecules using a Lipophilic Salt ApproachSeptember 27, 2016 11 AM ET (5 PM CET) Market Segment: Pharmaceutical Click here for access |
API in Capsule: A Smart Approach for Rapid Drug DevelopmentSeptember 14, 2016 10 AM ET (4 PM CET) Market Segment: Pharmaceutical Micro-dosing in Today’s Pharmaceutical Industry Micro-dosing is the procedure of dispensing precise amounts of drug substance into capsules (powder-in-capsule or PIC). Capsugel’s proprietary Xcelodose® Precision Powder Micro-dosing System facilitates the PIC approach by providing accurate, consistent and automated fill across compound types inclusive of very low dose applications. Xcelodose Systems have become the industry standard for micro-dosing with rapid PIC manufacture and fill accuracy to 100 micrograms. Micro-dosing best practices have been developed by Xcelience, based on the experience of more than 600 batches and 200 compounds, utilizing Xcelodose Systems to reduce product development time by 13-17 weeks. Key Learning Objectives:
Presented by:
API in Capsule: A Smart Approach for Rapid Drug DevelopmentSeptember 14, 2016 10 AM ET (4 PM CET) Market Segment: Pharmaceutical Click here for access |
Leading Edge HPMC Capsules – Bioequivalence and Functional PerformanceJuly 26, 2016 11 AM ET (5 PM CET) Market Segment: Pharmaceutical Two-piece hard shell capsules made from hydroxypropyl methylcellulose (HPMC) are emerging as an alternative to conventional gelatin capsules for oral drug delivery when there is a physical incompatibility with gelatin. A new HPMC-polymer capsule without secondary gelling agents developed through a thermo-gelation process (Vcaps Plus) has shown dissolution profiles similar to hard gelatin capsules, including pH and ionic independence. Although HPMC capsules are used in marketed drugs, there are few comparisons of the in-vivo performance between gelatin and HPMC in literature. In this webinar, experts will present the in-vitro dissolution and an in-vivo bioequivalence study comparing the performance of the identical formulation of three different drugs in Vcaps® Plus capsules to hard gelatin capsules. In addition, the circumstances under which the same API and formulation contained in HGC and Vcaps® Plus capsules can be expected to provide equivalent performance will be discussed. Presented by:
Register now! If this time doesn’t work for your schedule, register anyways, and we will send you a link to the on-demand version. Leading Edge HPMC Capsules – Bioequivalence and Functional PerformanceJuly 26, 2016 11 AM ET (5 PM CET) Market Segment: Pharmaceutical Click here for access |
Clean Label: Clear by Design - From Development to DeliveryJuly 13, 2016 11 AM ET (5 PM CET) Market Segment: Dietary Supplement With today’s consumer demanding transparency through a cleaner label, they want clear knowledge and understanding of the ingredients they are consuming. Supplement suppliers make choices during product development that ultimately affect the final product label. There are market ready solutions available to capture this market trend. This webinar will provide insight into the latest delivery technologies and excipients that support the growing clean label promise. Through case studies we will showcase the process and progress of a product developers’ choices to meet this market need. Please register using the link below. If this time does not work for your schedule, you can still register for the on-demand version. Clean Label: Clear by Design - From Development to DeliveryJuly 13, 2016 11 AM ET (5 PM CET) Market Segment: Dietary Supplement Click here for access |